GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute of the National Institutes of Health
Grant: 1F31CA271636-01
Small-molecule Inhibition of Glycogen Synthase Kinase-3 Sensitizes Colorectal Cancer Cells and Stimulates Immune Cells to Bolster Immune Cell-mediated Tumor Cytotoxicity
National Cancer Institute of the National Institutes of Health
Grant: 1S 10RR021051
NCRR NIH HHS
Grant: P20 RR025179
NCI NIH HHS
Grant: 5F31CA271636-02
NCI NIH HHS
Grant: F31 CA271636
NCRR NIH HHS
Grant: S10 RR021051
National Institutes of Health
Grant: 1S10RR021051-01A2
BD FACSAria Flow Cytometer
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals